JP2009538614A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538614A5 JP2009538614A5 JP2009512739A JP2009512739A JP2009538614A5 JP 2009538614 A5 JP2009538614 A5 JP 2009538614A5 JP 2009512739 A JP2009512739 A JP 2009512739A JP 2009512739 A JP2009512739 A JP 2009512739A JP 2009538614 A5 JP2009538614 A5 JP 2009538614A5
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial activity
- peptide
- concentration
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 33
- 239000000126 substance Substances 0.000 claims description 14
- 241000194033 Enterococcus Species 0.000 claims description 8
- 241000520134 Enterococcus mundtii Species 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 29
- 239000000203 mixture Substances 0.000 claims 22
- 125000003275 alpha amino acid group Chemical group 0.000 claims 14
- 238000000034 method Methods 0.000 claims 13
- 241001465754 Metazoa Species 0.000 claims 11
- 239000006041 probiotic Substances 0.000 claims 11
- 235000018291 probiotics Nutrition 0.000 claims 11
- 230000000529 probiotic effect Effects 0.000 claims 10
- 239000012634 fragment Substances 0.000 claims 7
- 241000194017 Streptococcus Species 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 208000035143 Bacterial infection Diseases 0.000 claims 5
- 208000022362 bacterial infectious disease Diseases 0.000 claims 5
- 239000007788 liquid Substances 0.000 claims 5
- 239000007921 spray Substances 0.000 claims 5
- 241000282412 Homo Species 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 4
- 241000588626 Acinetobacter baumannii Species 0.000 claims 3
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 3
- 239000002324 mouth wash Substances 0.000 claims 3
- 241000894007 species Species 0.000 claims 3
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 3
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims 2
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims 2
- 241000588697 Enterobacter cloacae Species 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 2
- 241000588747 Klebsiella pneumoniae Species 0.000 claims 2
- 241000589516 Pseudomonas Species 0.000 claims 2
- 241001288016 Streptococcus gallolyticus Species 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 244000052616 bacterial pathogen Species 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 239000006210 lotion Substances 0.000 claims 2
- 229940051866 mouthwash Drugs 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims 2
- 201000009890 sinusitis Diseases 0.000 claims 2
- 241000193755 Bacillus cereus Species 0.000 claims 1
- 241000193403 Clostridium Species 0.000 claims 1
- 241000588914 Enterobacter Species 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 241000186805 Listeria innocua Species 0.000 claims 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 241000191965 Staphylococcus carnosus Species 0.000 claims 1
- 239000005862 Whey Substances 0.000 claims 1
- 102000007544 Whey Proteins Human genes 0.000 claims 1
- 108010046377 Whey Proteins Proteins 0.000 claims 1
- 240000008042 Zea mays Species 0.000 claims 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 229940041514 candida albicans extract Drugs 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 235000005822 corn Nutrition 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000008176 lyophilized powder Substances 0.000 claims 1
- 235000013379 molasses Nutrition 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 230000035764 nutrition Effects 0.000 claims 1
- 239000005022 packaging material Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 206010039083 rhinitis Diseases 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000003356 suture material Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 206010044008 tonsillitis Diseases 0.000 claims 1
- 239000012138 yeast extract Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200604035A ZA200604035B (en) | 2005-05-31 | 2006-05-28 | Improved grenade launcher |
| PCT/IB2007/051982 WO2007138538A2 (en) | 2006-05-28 | 2007-05-25 | Probiotic strain and antimicrobial peptide derived therefrom |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538614A JP2009538614A (ja) | 2009-11-12 |
| JP2009538614A5 true JP2009538614A5 (https=) | 2010-06-24 |
Family
ID=38779065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009512739A Pending JP2009538614A (ja) | 2006-05-28 | 2007-05-25 | プロバイオティクス菌株及びこれに由来する抗菌性ペプチド |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7951385B2 (https=) |
| EP (1) | EP2021457B1 (https=) |
| JP (1) | JP2009538614A (https=) |
| KR (1) | KR101521123B1 (https=) |
| CN (1) | CN101454440B (https=) |
| AP (1) | AP2841A (https=) |
| AU (1) | AU2007266675B2 (https=) |
| CA (1) | CA2647161A1 (https=) |
| EA (1) | EA017558B1 (https=) |
| IL (2) | IL195520A0 (https=) |
| NO (1) | NO20084577L (https=) |
| NZ (1) | NZ571619A (https=) |
| WO (1) | WO2007138538A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101521123B1 (ko) * | 2006-05-28 | 2015-05-19 | 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 | 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드 |
| US8357519B2 (en) * | 2008-11-19 | 2013-01-22 | The Ohio State University | Methods and processes for producing esters |
| WO2011045764A1 (en) * | 2009-10-15 | 2011-04-21 | Cipla Medpro Research And Development (Pty) Ltd | A product for delivering antimicrobially active substances to an infected site |
| JP5881017B2 (ja) * | 2010-11-05 | 2016-03-09 | 国立大学法人広島大学 | 籾殻または玄米から単離された植物乳酸菌およびその利用 |
| WO2012148891A1 (en) * | 2011-04-29 | 2012-11-01 | Evonik Degussa Corporation | Peptide-lipid conjugates and uses thereof |
| RU2532227C1 (ru) * | 2013-10-23 | 2014-10-27 | Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) | Штамм enterоcoccus mundtii, продуцирующий субстанцию пептидной природы с антилистериозной активностью |
| RU2599430C1 (ru) * | 2015-07-23 | 2016-10-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | ШТАММ ЛАКТОБАКТЕРИЙ Enterococcus mundtii - ПРОДУЦЕНТ МОЛОЧНОЙ КИСЛОТЫ И АНТИБИОТИЧЕСКИХ ВЕЩЕСТВ |
| US9944960B2 (en) * | 2015-11-17 | 2018-04-17 | Premier Research Labs, Lp | Process for microbial production of dihydrolipoic acid and extraction of dihydrolipoic acid with edible oils |
| CN105385636A (zh) * | 2015-12-07 | 2016-03-09 | 江南大学 | 一株产细菌素的肠膜明串珠菌及其应用 |
| AU2017240064B8 (en) | 2016-03-31 | 2021-11-11 | Gojo Industries, Inc. | Antimicrobial peptide stimulating sanitizing composition |
| EP3436041B1 (en) | 2016-03-31 | 2023-05-24 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| WO2017173240A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| KR101722255B1 (ko) * | 2016-04-22 | 2017-04-03 | 주식회사 폴인브레드 | 쌀과 쌀누룩을 이용한 자연발효종 제조방법 |
| JP2020500860A (ja) | 2016-11-23 | 2020-01-16 | ゴジョ・インダストリーズ・インコーポレイテッド | プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物 |
| AU2018336988B2 (en) * | 2017-09-19 | 2023-06-22 | Advaxis, Inc. | Compositions and methods for lyophilization of bacteria or Listeria strains |
| WO2019151371A1 (ja) * | 2018-01-31 | 2019-08-08 | ニュートリー株式会社 | 肺炎球菌感染症の予防及び／又は治療剤 |
| KR102076089B1 (ko) | 2018-10-02 | 2020-02-11 | 서울대학교 산학협력단 | 니신 z 생산능이 우수한 락토코커스 락티스 서브스페시스 락티스 ldtm 6804 신균주(kctc 13564bp) |
| CN109456911B (zh) * | 2018-10-10 | 2019-10-18 | 南京林业大学 | 一株蒙氏肠球菌HcM7及其应用 |
| CN110846260B (zh) * | 2019-12-18 | 2021-03-02 | 江南大学 | 一株降低生物胺的肉葡萄球菌及其应用 |
| KR102951826B1 (ko) * | 2023-01-18 | 2026-04-13 | 조선대학교산학협력단 | 오리 유래 항균 펩타이드로부터 설계된 신규 항균 펩타이드 및 이의 용도 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1084969A (ja) | 1996-09-19 | 1998-04-07 | Chemo Sero Therapeut Res Inst | ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法 |
| US7655775B2 (en) * | 1997-09-05 | 2010-02-02 | Canbiocin, Inc. | Expression vectors for treating bacterial infections |
| AU7898700A (en) | 1999-10-22 | 2001-05-08 | Shanghai Bio Road Gene Development Ltd. | A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide |
| GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
| DE10105347A1 (de) * | 2001-02-05 | 2002-08-22 | Nutrinova Gmbh | Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht |
| GB0125535D0 (en) | 2001-10-24 | 2001-12-12 | Microbiological Res Authority | Mycobacterial genes down-regulated during latency |
| US6878373B2 (en) | 2001-12-03 | 2005-04-12 | Micropure Technologies, Inc. | Probiotic composition containing Bacillus cereus RRRL B-30535 |
| JP4111489B2 (ja) * | 2002-05-23 | 2008-07-02 | プリマハム株式会社 | 新規バクテリオシン |
| WO2004005492A2 (fr) * | 2002-07-03 | 2004-01-15 | Galina Gennadievna Alekhina | Composition probiotique a base d'une souche d'enterocoques pour moyens de traitement et de prevention et procede de fabrication correspondant |
| EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| ITBO20020564A1 (it) | 2002-09-06 | 2004-03-07 | Alfa Wassermann Spa | Bifidobatteri e preparazioni che li contengono. |
| KR101521123B1 (ko) * | 2006-05-28 | 2015-05-19 | 시플라 메드프로 리서치 앤드 디벨롭먼트 (피티와이) 엘티디 | 프로바이오틱 스트레인 및 그로부터 유도된 항균 펩티드 |
-
2007
- 2007-05-25 KR KR1020087031307A patent/KR101521123B1/ko not_active Expired - Fee Related
- 2007-05-25 EA EA200802409A patent/EA017558B1/ru not_active IP Right Cessation
- 2007-05-25 US US12/302,067 patent/US7951385B2/en active Active
- 2007-05-25 JP JP2009512739A patent/JP2009538614A/ja active Pending
- 2007-05-25 CA CA002647161A patent/CA2647161A1/en not_active Abandoned
- 2007-05-25 AU AU2007266675A patent/AU2007266675B2/en not_active Ceased
- 2007-05-25 WO PCT/IB2007/051982 patent/WO2007138538A2/en not_active Ceased
- 2007-05-25 EP EP07736018.8A patent/EP2021457B1/en active Active
- 2007-05-25 AP AP2008004626A patent/AP2841A/xx active
- 2007-05-25 NZ NZ571619A patent/NZ571619A/en not_active IP Right Cessation
- 2007-05-25 CN CN2007800198580A patent/CN101454440B/zh not_active Expired - Fee Related
-
2008
- 2008-11-03 NO NO20084577A patent/NO20084577L/no not_active Application Discontinuation
- 2008-11-26 IL IL195520A patent/IL195520A0/en unknown
-
2011
- 2011-04-26 US US13/094,155 patent/US8444998B2/en not_active Expired - Fee Related
-
2017
- 2017-02-16 IL IL250634A patent/IL250634A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009538614A5 (https=) | ||
| US7713726B2 (en) | Inhibition of pathogens by probiotic bacteria | |
| CN105087423A (zh) | 新型芽孢杆菌cjbv及含有其的抗菌组合物 | |
| CN107847527A (zh) | 微生物感染的预防和治疗 | |
| CA2389982A1 (en) | Inhibition of pathogens by bacillus coagulans strains | |
| EP3795169B1 (en) | Bacteriophage-derived recombinant protein having antimicrobial activity against pathogenic gram-negative bacteria | |
| JP5622110B2 (ja) | 新規乳酸菌 | |
| Saleem et al. | Comparative study of two bacteriocins produced by representative indigenous soil bacteria. | |
| EP3845237B1 (en) | Ablysin for treating multidrug-resistant bacteriall infections | |
| CN111320678B (zh) | 抗菌肽突变体及其应用 | |
| US12220448B2 (en) | Method of treating pathogenic bacterial infectious diseases | |
| CN107794232B (zh) | 拮抗痤疮丙酸杆菌和革兰氏阳性菌生长的链球菌及其代谢产物 | |
| CA2711462A1 (en) | Novel antibiotic peptide derived from ribosomal protein l 1 of helicobacter pylori and use thereof | |
| KR102637772B1 (ko) | 위건강과 구강질환 관련 미생물 및 병원성 미생물에 대한 항균활성을 갖는 산삼 유래 락토바실러스 플란타럼 wg.q7 균주 및 이의 용도 | |
| KR102951826B1 (ko) | 오리 유래 항균 펩타이드로부터 설계된 신규 항균 펩타이드 및 이의 용도 | |
| CN116120419B (zh) | 一种新型抗菌肽及其应用 | |
| KR102275801B1 (ko) | 시스-자스몬을 포함하는 바이오필름 형성 억제용 조성물 | |
| US20240293482A1 (en) | Compositions and methods for treating biofilms, infections and periodontitis | |
| KR20060108964A (ko) | 엔테로코커스 패칼리스 ｃｂｔ―ｓｌ（5）, 이를 이용한항균 배양액 분리농축물의 제조 방법 및 이를 포함하는조성물 | |
| KR102342160B1 (ko) | 탁시폴린을 포함하는 바이오필름 형성 억제용 조성물 | |
| US9802982B2 (en) | Peptide and uses thereof | |
| US20230381249A1 (en) | Probiotic strain for countering caries pathogens | |
| KR102441377B1 (ko) | 펙토리나린을 포함하는 바이오필름 형성 억제용 조성물 | |
| Xiaodong et al. | Optimisation of culture conditions for antagonism of Vancomycin-resistant Staphylococcus aureus by Streptococcus D-19 of upper respiratory tract | |
| CZ2017797A3 (cs) | Terapeutický prostředek na bázi bakteriálních lyzátů |